On July 22, 2019, the Food and Drug Administration (“FDA”) released its fourth warning letter for cannabidiol (“CBD”) related products since the enactment of the 2018 Federal Farm Bill in December. Though not a formal action or rule-making by the…
By: Miller & Martin PLLC
SOURCE: Personal Injury & Products Liability RSS Feed | JD Supra Law News – Read entire story here.